News Release(2010)

September 17, 2010

License Agreement of "iron-oxyhydroxide" for the treatment of hyperphosphatemia in dialysis patients

July 2, 2010

Preliminary Results of Phase III clinical study of KUC-7483

May 26, 2010

Announcement for Launching "Epoetin Alfa BS Injection [JCR]", a Treatment Agent for Renal Anemia

April 30, 2010

License Agreement of "Genetically Engineered Proaerolysin" for the Treatment of Benign Prostatic Hyperplasia

February 4, 2010

European Commission Approved SILODOSIN (Brand Name in Japan: Urief®) for The Treatment of Dysuria Associated with Benign Prostatic Hyperplasia